TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Mochida Pharmaceutical Co., Ltd. ( (JP:4534) ) has issued an announcement.
Mochida Pharmaceutical Co., Ltd. reported a strong financial performance for the six months ending September 30, 2025, with net sales increasing by 7.6% and operating profit rising by 31% compared to the previous year. The company’s comprehensive income surged by 131.8%, reflecting robust growth and improved profitability, which may positively impact its market position and stakeholder confidence.
The most recent analyst rating on (JP:4534) stock is a Hold with a Yen3191.00 price target. To see the full list of analyst forecasts on Mochida Pharmaceutical Co., Ltd. stock, see the JP:4534 Stock Forecast page.
More about Mochida Pharmaceutical Co., Ltd.
Mochida Pharmaceutical Co., Ltd. is a company listed on the Tokyo Stock Exchange, operating in the pharmaceutical industry. It focuses on the development and sale of pharmaceutical products, with a significant emphasis on innovation and market expansion.
Average Trading Volume: 26,240
Technical Sentiment Signal: Sell
Current Market Cap: Yen100.3B
See more insights into 4534 stock on TipRanks’ Stock Analysis page.